Reciprocal modulation between Sp1 and Egr-1

Journal of Cellular Biochemistry

Volumn 66, Issue 4, 1997, Pages 489-499

  Huang, Ruo Pan ^b   Fan, Yan ^b   Ni, Zhengyu ^a   Mercola, Dan ^c,d   Adamson, Eileen D ^a  

^a BURNHAM INSTITUTE   (United States)

^b NORTHWEST HOSPITAL   (United States)

^c SIDNEY KIMMEL CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Competition; Gel retardation; Immunoblotting; Overexpression; Reporter gene activation; Synthetic DNA binding site

Indexed keywords

TRANSCRIPTION FACTOR SP1; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; DROSOPHILA; GENE EXPRESSION; HUMAN; HUMAN CELL; INSECT; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CONSENSUS SEQUENCE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENES; IMMEDIATE-EARLY PROTEINS; KERATINS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; ZINC FINGERS;

ANIMALIA; INSECTA; MAMMALIA;

EID: 0030819912     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H     Document Type: Article

References (44)

1. Ackerman SL, Minden AG, Williams GT, Bobonis C, Yeung C-Y (1991): Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter. Proc Natl Acad Sci USA 88:7523-7527.
2. Ackerman SL, Minden AG, Yeung C-Y (1993): The minimal self-sufficient element in a murine G + C-rich promoter is a large element with imperfect dyad symmetry. Proc Natl Acad Sci USA 90:11865-11869.
3. Chen X, Azizkhan JC, Lee DC (1992): The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor a promoter. Oncogene 7:1805-1815.
4. Chen X, Wright KL, Berkowitz EA, Azizkhan JC, Ting JP-Y, Lee DC (1994): Protein interactions at Sp-1 likes sites in the TGFα promoter as visualized by in vivo genomic footprinting. Oncogene 9:3179-3187.
5. Christy B, Nathans D (1989): DNA-binding site of the growth factor-inducible protein Zif268. Proc Natl Acad Sci USA 86:8737-8741.
6. Cohen HT, Bossone SA, Zhu G, McDonald GA, Sukhatme VP (1997): Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem 272:2901-2913.
7. Courey AJ, Tjian R (1988): Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-898.
8. Cui MZ, Parry GCN, Oeth P, Larson H, Smith M, Huang RP, Adamson ED, Mackman N (1996): Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem 271: 2731-2739.
9. Ebert SN, Wong DL (1995): Differential activation of the rat phenylethanolamine N-methyltransferase gene by Sp1 and Egr-1. J Biol Chem 270:17299-17305.
10. Geiser AG, Kim SJ, Roberts AB, Sporn MB (1991): Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 11:84-92.
11. Gunther M, Frebourg T, Laithier M, Fossar N, Bouziane-Ouartini M, Lavialle C, Brison O (1995): An Sp1 binding site and the minimal promoter contribute to overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line. Mol Cell Biol 15:2490-2499.
12. Hofmann W, Royer H-D, Drechsler M, Schneider S, Royer-Pokora B (1993): Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene 8:3123-3131.
13. Huang R-P, Adamson ED (1993): Characterization of the DNA-binding activity of the early growth response-1 (EGR-1) transcription factor: Evidence for modulation by a redox mechanism. DNA and Cell Biology 12:265-273.
14. Huang R-P, Adamson ED (1994): The phosphorylated forms of the transcription factor, Egr-1, bind to DNA more efficiently than non-phosphorylated. Biochem Biophys Res Commun 200:1271-1276.
15. Huang R-P, Darland T, Okamura D, Mercola D, Adamson ED (1994a): Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 9:1367-1377.
16. Huang R-P, Ngo L, Okamura D, Tucker M, Adamson ED (1994b): V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras and c-Raf-1. J Cell Biochem 56:469-479.
17. Huang R-P, Liu C-T, Fan Y, Mercola DA, Adamson ED (1995): Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 55: 5054-5062.
18. Huang R-P, Wu J-X, Fan Y, Adamson ED (1996): UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol 133:211-220.
19. Huang R-P, Fan Y, de Belle I, Niemeyer C, Mercola D, Gottardis MM, Adamson ED (1997): Decreased Egr-1 expression in human, mouse and rat mammary cell and tissues correlates with tumor formation. Int J Cancer (in press).
20. Itoh F, Ishizaka Y, Tahira T, Yamamoto M, Miya A, Imai K, Yachi A, Takai S, Sugimura T, Nagao M (1992): Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients. Oncogene 7:1201-1206.
21. Jackson SP, MacDonald JJ, Lees-Miller S, Tjian R (1990): GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63:155-165.
22. Jordano J, Perucho M (1988): Initial characterization of a potential transcriptional enhancer for the human c-K-ras gene. Oncogene 2:359-366.
23. Kaetzel DMJ, Maul RS, Liu B, Bonthron D, Fenstermaker RA, Coyne DW (1994): Platelet-derived growth factor A-chain gene transcription is mediated by positive and negative regulatory regions in the promoter. Biochem J 301:321-327.
24. Kageyama R, Merlino GT, Pastan I (1988): Epidermal growth factor (EGF) receptor gene transcription: Requirement for SP1 and an EGF receptor-specific factor. J Biol Chem 263:6326-6329.
25. Karlseder J, Rotheneder H, Wintersberger E (1996): Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16:1659-1667.
26. Leggatt RW, Armstrong SA, Barry D, Mueller CR (1995): Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J Biol Chem 270:25879-25884.
27. Lin J-X, Leonard WJ (1997): Immediate early gene product Egr-1 regulates the human interleukin 2 receptor β-chain promoter through noncanonical Egr and Sp1 binding sites. Mol Cell Biol 17: 3714-3722.
28. Liu C, Adamson E, Mercola D (1996): Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor β1. Proc Natl Acad Sci USA 93: 11831-11836.
29. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJI (1991): Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253:1550-1553.
30. Madden SL, Cook DM, Rauscher FJI (1993): A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene 8:1713-1720.
31. Majello B, De Luca P, Suske G, Lania L (1995): Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. Oncogene 10:1841-1848.
32. Molnar G, Crozat A, Pardee AB (1994): The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol 14:5242-5248.
33. Nardelli J, Gibson TJ, Vesque C, Charnay P (1991): Base sequence discrimination by Zinc-finger DNA-binding domains. Nature 349:175-178.
34. Ragona G, Edwards SA, Mercola DA, Adamson ED, Calogero A (1991): The transcriptional factor Egr-1 is synthesized by Baculovirus-infected insect cells in an active, UNA-binding form. DNA and Cell Biology 10:61-66.
35. Rauscher FJI, Morris JF, Tournay OE, Cook DM, Curran T (1990): Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250: 1259-1262.
36. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning." 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
37. Shingu T, Bornstein P (1994): Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J Biol Chem 269:32551-32557.
38. Sif S, Gilmore TD (1994): Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J Virol 68: 7131-7138.
39. Sif S, Capobianco AJ, Gilmore TD (1993): The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts. Oncogene 8:2501-2509.
40. Skerka C, Decker EL, Zipfel PF (1995): A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and Egr-1. J Biol Chem 270:22500-22506.
41. Sukhatme VP (1990): Early transcriptional events in cell growth: the Egr family. J Am Soc Nephrol 1:859-866.
42. Wang ZY, Madden SL, Deuel TF, Rauscher FJ III (1992): The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-22002.
43. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FJI, Sens DA, Garvin AJ, LeRoith D, Roberts CT Jr (1993a): Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci USA 90:5828-5832.
44. Werner H, Roberts CT Jr, LeRoith D (1993b): The regulation of IGF-I receptor gene expression by positive and negative zinc-finger transcription factors. Adv Exp Med Biol 343:91-103.